NuvoBio is a bio-medical technology company dedicated to expediting the development of peptide therapeutics. Using our novel Darwin AI technology platform to design highly specific binding peptides, we are developing intellectual property and advancing research and development in the areas of new synthetic drugs, immunotherapies and other unique applications.
Powered by our DARWIN AI platform, smart solutions are at the core of all that we do at NuvoBio.